NPPA computed the Retail Price of Gliclazide IP 80 mg + Metformin Hydrochloride 500 mg for M/s Alkem Healthscience (A unit of Alkem Laboratories Ltd.) (Manufacturer) & M/s Alkem Wellness Ltd. (Marketer)

Mar 24, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 23, 2026, issued the Computation of Retail Price of Gliclazide IP 80 mg + Metformin Hydrochloride 500 mg for M/s Alkem Healthscience (A unit of Alkem Laboratories Ltd.) (Manufacturer) & M/s Alkem Wellness Ltd. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from July 2025

• The Retail Price has been computed for Each Film Coated Tablet Containing Gliclazide IP 80 mg + Metformin Hydrochloride 500 mg for M/s Alkem Healthscience (A unit of Alkem Laboratories Ltd.) (Manufacturer) & M/s Alkem Wellness Ltd. (Marketer)

• The Total MAT is 2,99,23,70,459

[Notification No. 19(5040)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT